STATE STREET CORP - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 43 filers reported holding VYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$63,014
+34.1%
420,092
+100.0%
0.00%
Q3 2022$47,000
-42.7%
210,0460.0%0.00%
Q2 2022$82,000
-38.3%
210,046
+3.0%
0.00%
Q1 2022$133,000
-76.0%
203,846
-62.5%
0.00%
Q4 2021$555,000
-26.6%
544,0130.0%0.00%
Q3 2021$756,000
-59.7%
544,013
+1.8%
0.00%
Q2 2021$1,876,000
-71.4%
534,613
-44.3%
0.00%
Q1 2021$6,566,000959,1980.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders